Description
Filgotinib-[d4] is a deuterium labelled form of Filgotinib. Filgotinib is a potent and selective JAK1 inhibitor exhibiting 30-fold selectivity over JAK2. Filgotinib has the potential for the treatment of rheumatoid arthritis and possibly other immune-inflammatory diseases